TY - JOUR
T1 - Parents' priorities and preferences for treatment of children with ADHD
T2 - Qualitative inquiry in the MADDY study
AU - Lu, Stacy V.
AU - Leung, Brenda M.Y.
AU - Bruton, Alisha M.
AU - Millington, Elizabeth
AU - alexander, E.
AU - Camden, Kelsey
AU - Hatsu, Irene
AU - Johnstone, Jeanette M.
AU - Arnold, L. Eugene
N1 - Funding Information:
Dr. Arnold has received research funding from Supernus Pharmaceuticals (USA), Roche/Genentech Pharmaceuticals (Switzerland), Otsuka Pharmaceuticals (Japan), YoungLiving Essential Oils (USA) and National Institute of Health (USA, R01 MH 100144); has consulted with Pfizer Parmaceuticals (USA); and has been on advisory boards for Otsuka (Japan) and Roche/Genentech (Switzerland). Other authors have no conflicts of interest relevant to this article to disclose.
Funding Information:
We thank the parents of the MADDY study for their time and input into the interviews. We also thank the research assistants who assisted with data collection: Leanna Eiterman (LE), Maddy Stern (MS) and Lisa Robinette (LR) at OSU and Hayleigh Ast (HA) at OHSU. We are grateful to Dr. Bonnie Kaplan for spearheading fundraising that ultimately allowed the three sites to initiate this research in North America. We acknowledge funding for the study from the Nutrition and Mental Health Research Fund, managed by the Foundation for Excellence in Mental Health Care (FEMHC), and the Gratis Foundation. Dr. Johnstone was supported by an NIH‐NCCIH 5R90AT00892403 through the National University for Natural Medicine, an NIH‐NCCIH T32 AT002688, the Department of Child and Adolescent Psychiatry, Oregon Health & Science University and Oregon Clinical & Translational Research, through the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000128. Dr. Gracious' time in assisting in study development was supported by the Jeffrey Research Fellowship, The OSU Department of Psychiatry & Behavioral Health. The study was also supported by The Ohio State University Center for Clinical and Translational Science award (National Center for Advancing Translational Sciences, Grant 8UL1TR000090‐05) and the OSU Department of Human Sciences. The study at the Canadian site is funded by the Nutrition and Mental Health Research Fund, administered by the Calgary Foundation. Dr. Leung's position is supported by the Emmy Droog (endowed) chair in Complementary and Alternative Healthcare.
Funding Information:
We thank the parents of the MADDY study for their time and input into the interviews. We also thank the research assistants who assisted with data collection: Leanna Eiterman (LE), Maddy Stern (MS) and Lisa Robinette (LR) at OSU and Hayleigh Ast (HA) at OHSU. We are grateful to Dr. Bonnie Kaplan for spearheading fundraising that ultimately allowed the three sites to initiate this research in North America. We acknowledge funding for the study from the Nutrition and Mental Health Research Fund, managed by the Foundation for Excellence in Mental Health Care (FEMHC), and the Gratis Foundation. Dr. Johnstone was supported by an NIH-NCCIH 5R90AT00892403 through the National University for Natural Medicine, an NIH-NCCIH T32 AT002688, the Department of Child and Adolescent Psychiatry, Oregon Health & Science University and Oregon Clinical & Translational Research, through the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000128. Dr. Gracious' time in assisting in study development was supported by the Jeffrey Research Fellowship, The OSU Department of Psychiatry & Behavioral Health. The study was also supported by The Ohio State University Center for Clinical and Translational Science award (National Center for Advancing Translational Sciences, Grant 8UL1TR000090-05) and the OSU Department of Human Sciences. The study at the Canadian site is funded by the Nutrition and Mental Health Research Fund, administered by the Calgary Foundation. Dr. Leung's position is supported by the Emmy Droog (endowed) chair in Complementary and Alternative Healthcare.
Publisher Copyright:
© 2022 John Wiley & Sons, Ltd.
PY - 2022/9
Y1 - 2022/9
N2 - Background: Parents' lived experiences of having a child with ADHD may shape their decision making regarding ADHD treatment options for their child. The aim of this study was to explore parents' experiences of living with a child with ADHD in the family and how their experiences influence their perspectives on treatment preferences and priorities. Methods: A phenomenological qualitative design was used. Semistructured interviews were conducted with parents of children with ADHD who were enrolled in a multisite randomized controlled trial. Interviews were transcribed verbatim, and transcripts at each site were double coded. Initial codes were derived directly from the text. Qualitative data were analysed with an inductive approach. Results: Twenty-three parents were interviewed: eight from Alberta, Canada; eight from Portland, Oregon, USA; and seven from Columbus, Ohio, USA. Among the parents, 69% were married, 86% completed college education and 52% reported household income over $80,000. Among the children, the mean age was 9.6 years (SD = 1.8 years), 78% were boys and 48% were never medicated for their ADHD. Two major themes emerged from the analysis. Theme 1 was ‘impact of ADHD on families within and outside the home’ with the following subthemes: ‘reconfiguring the home life’, ‘trial-and-error of accommodations at school’ and ‘responding to social pressures to fit in’. Theme 2 was ‘enabling appropriate and accessible treatments for families’ with the following subthemes: ‘finding the “right fit” with professionals and treatments’ and ‘factors influencing inequitable access to treatments’. Conclusions: Parents described shared experiences and identified similar barriers, preferences and priorities for ADHD treatments regardless of demographic differences by site. Families desired access to family-centred, multimodal approaches to ADHD treatment. Further research is needed to identify the specific structural changes to healthcare, services and policies that will better support this approach.
AB - Background: Parents' lived experiences of having a child with ADHD may shape their decision making regarding ADHD treatment options for their child. The aim of this study was to explore parents' experiences of living with a child with ADHD in the family and how their experiences influence their perspectives on treatment preferences and priorities. Methods: A phenomenological qualitative design was used. Semistructured interviews were conducted with parents of children with ADHD who were enrolled in a multisite randomized controlled trial. Interviews were transcribed verbatim, and transcripts at each site were double coded. Initial codes were derived directly from the text. Qualitative data were analysed with an inductive approach. Results: Twenty-three parents were interviewed: eight from Alberta, Canada; eight from Portland, Oregon, USA; and seven from Columbus, Ohio, USA. Among the parents, 69% were married, 86% completed college education and 52% reported household income over $80,000. Among the children, the mean age was 9.6 years (SD = 1.8 years), 78% were boys and 48% were never medicated for their ADHD. Two major themes emerged from the analysis. Theme 1 was ‘impact of ADHD on families within and outside the home’ with the following subthemes: ‘reconfiguring the home life’, ‘trial-and-error of accommodations at school’ and ‘responding to social pressures to fit in’. Theme 2 was ‘enabling appropriate and accessible treatments for families’ with the following subthemes: ‘finding the “right fit” with professionals and treatments’ and ‘factors influencing inequitable access to treatments’. Conclusions: Parents described shared experiences and identified similar barriers, preferences and priorities for ADHD treatments regardless of demographic differences by site. Families desired access to family-centred, multimodal approaches to ADHD treatment. Further research is needed to identify the specific structural changes to healthcare, services and policies that will better support this approach.
KW - ADHD
KW - ADHD treatment
KW - lived experience
KW - parents
KW - phenomenological
KW - qualitative
KW - treatment decision making
UR - http://www.scopus.com/inward/record.url?scp=85127270617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127270617&partnerID=8YFLogxK
U2 - 10.1111/cch.12995
DO - 10.1111/cch.12995
M3 - Article
C2 - 35244227
AN - SCOPUS:85127270617
SN - 0305-1862
VL - 48
SP - 852
EP - 861
JO - Child: Care, Health and Development
JF - Child: Care, Health and Development
IS - 5
ER -